Updates on first-line therapy for metastatic pancreatic adenocarcinoma.


Pancreatic adenocarcinoma is the 10th most common malignancy in the United States but is responsible for the 4th most cancer related deaths. This disease can only be potentially cured through early discovery and complete surgical resection. Unfortunately, nearly half of patients have metastatic spread at presentation. Combination chemotherapy with… (More)
DOI: 10.6092/1590-8577/2279


3 Figures and Tables

Cite this paper

@article{Marks2014UpdatesOF, title={Updates on first-line therapy for metastatic pancreatic adenocarcinoma.}, author={Eric I Marks and Muhammad Wasif Saif and Yuxia Jia}, journal={JOP : Journal of the pancreas}, year={2014}, volume={15 2}, pages={99-102} }